8-K: Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates

SECNov 27 16:48 ET · Announcements

Windtree Therapeutics Reports Q3 EPS ($4.23) Vs. ($15.47) Last Year

TipRanksNov 27 16:10 ET

Express News | Windtree Therapeutics: Believe We Have Sufficient Resources Available to Fund Business Operations Through Jan 2025

ReutersNov 27 16:05 ET

Express News | Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates

ReutersNov 27 16:05 ET

Press Release: Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates

Dow JonesNov 27 16:05 ET

Windtree Therapeutics 3Q Loss/Shr $4.23 >WINT

Dow JonesNov 27 16:05 ET